Hirst et al., 2003 - Google Patents
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression …Hirst et al., 2003
View PDF- Document ID
- 11008324984712476072
- Author
- Hirst C
- Buzza M
- Bird C
- Warren H
- Cameron P
- Zhang M
- Ashton-Rickardt P
- Bird P
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
Granzyme B (grB) is a serine proteinase released by cytotoxic lymphocytes (CLs) to kill abnormal cells. GrB-mediated apoptotic pathways are conserved in nucleated cells; hence, CLs require mechanisms to protect against ectopic or misdirected grB. The …
- 102100004391 GZMB 0 title abstract description 126
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hirst et al. | The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency | |
| van den Berg et al. | Divergent effects of tumor necrosis factor α on apoptosis of human neutrophils | |
| Ramírez-Labrada et al. | All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity | |
| Neumann et al. | Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells | |
| Lens et al. | The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes | |
| Truman et al. | CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis | |
| Jung et al. | Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2 | |
| Van der Meer et al. | Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells | |
| Römer et al. | Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412 | |
| Huber et al. | Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2 | |
| Le Gal et al. | HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes | |
| Bade et al. | Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes | |
| Kim et al. | Defective Notch activation in microenvironment leads to myeloproliferative disease | |
| Sinha et al. | Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL | |
| Shang et al. | Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts | |
| Aschkenazi et al. | Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells | |
| Dzionek et al. | BDCA-2, a novel plasmacytoid dendritic cell–specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction | |
| Liu et al. | NF‐κB protects from the lysosomal pathway of cell death | |
| Schmitz et al. | An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death | |
| El-Sukkari et al. | The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation | |
| Straszewski‐Chavez et al. | X‐linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas‐mediated apoptosis | |
| Verjan Garcia et al. | SIRPα/CD172a regulates eosinophil homeostasis | |
| Park et al. | The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation | |
| Alvarez et al. | Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity | |
| Bajramovic et al. | Presentation of αB-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination |